 Based on emerging evidence from animal models, IL-17 has been suggested as a target for anti-inflammatory therapies to improve recovery post-stroke and to reduce the formation of skin cancer.IL-17 has also been implicated in multiple sclerosis.The active form of vitamin D has been found to 'severely impair'  production of the IL-17 and IL-17F cytokines by Th17 cells.